Meeting
2013 ASCO Annual Meeting
OPTIMA prelim: Optimal personalized treatment of early breast cancer using multiparameter tests.
Authors
Rob Stein
University College London Hospitals NHS Foundation Trust, London, United Kingdom
Rob Stein , Andreas Makris , Luke Hughes-Davies , Amy Frances Campbell , Andrea Marshall , John M. S. Bartlett , Jenny Donovan , Christopher McCabe , David A. Cameron , Peter Canney , Adele Francis , Adrienne Morgan , Sarah Pinder , Daniel Rea , Peter Hall , Nigel Stallard , Helen B Higgins , Claire Hulme , Victoria Harmer , Janet A. Dunn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Clinical Trial Registration Number
ISRCTN42400492
Citation
J Clin Oncol 31, 2013 (suppl; abstr TPS656)
DOI
10.1200/jco.2013.31.15_suppl.tps656
Abstract #
TPS656
Poster Bd #
15G
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Disparity between Ki67 measurements and tumor gene expression tests in patients with hormone-sensitive early breast cancer from the OPTIMA preliminary trial.
First Author: Robert C. Stein
Poster
2021 ASCO Quality Care Symposium
Characterizing attitudes related to child-bearing in young women diagnosed with early breast cancer (EBC).
First Author: Saumya Umashankar
Poster
2020 ASCO Virtual Scientific Program
HER2 status and prediction of extended endocrine benefit with breast cancer index (BCI) in HR+ patients in the adjuvant tamoxifen: To offer more? (aTTom) trial.
First Author: John Bartlett
Poster
2016 ASCO Quality Care Symposium
Breast oncology precision medicine: Genomic testing and treatment at the population level.
First Author: Christopher Ryan Friese